ARTICLE | Clinical News
Shire preclinical data
November 12, 2007 8:00 AM UTC
In rats, Dynepo corrected the reduction in nerve conduction velocity that is associated with neuropathy. The compound was given at doses below those that prompt hematopoiesis. Data on the gene-activat...